ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,437 | -59.2% | 4,887 | -63.4% | 0.06% | -70.7% |
| Q3 2022 | $553,000 | +41.1% | 13,355 | +147.7% | 0.22% | -1.4% |
| Q1 2022 | $392,000 | -23.3% | 5,392 | +0.5% | 0.22% | -53.1% |
| Q2 2021 | $511,000 | +150.5% | 5,364 | +66.9% | 0.46% | +244.4% |
| Q2 2019 | $204,000 | -61.6% | 3,214 | -71.9% | 0.14% | -12.9% |
| Q4 2017 | $531,000 | +149.3% | 11,453 | +186.3% | 0.16% | +158.3% |
| Q3 2017 | $213,000 | -27.1% | 4,000 | +53.8% | 0.06% | -73.5% |
| Q4 2015 | $292,000 | – | 2,600 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |